Homo sapiens
source_name
Blood
tissue
Blood
cell type
FACS-sorted CD3+ cells
treatment
Ustekinumab (90 mg) in in combination with low-dose cyclophosphamide and steroids, following the RITUXVAS trial approach
library type
mRNA+ADT+HTO
cellranger version
7.1.0
reference genome
refdata-gex-GRCh38-2020-A
feature reference
feature_reference_1.csv
geo_loc_name
missing
collection_date
missing